Formula: | C21H31N5O2 |
Molecular Weight: | 385.51 |
Rotatable Bond Donors: | 4 |
clogP: | 1.69 |
Topological Polar Surface Area: | 72.54 |
Lipinski's RO5: | MW: 385.51 HBA: 7 HBD: 1 RB: 4 LogP: 1.69 |
Rule of Three: | MW: 385.51 HBA: 7 HBD: 1 RB: 4 LogP: 1.69 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS32283 | 0.71 | EOS32283 RDKit 3D 26 29 0 0 0 0 0 0 0 0999 V2000 -2.2004 4.0511 -1.7007 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2141 3.2061 -0.4447 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9087 4.1136 0.7279 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2277 2.1385 -0.5358 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5694 1.2419 -1.6412 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0675 -0.1369 -1.2563 C 0 0 1 0 0 0 0 0 0 0 0 0 0.2643 -0.4219 -1.9240 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2520 -0.4213 -0.8819 N 0 0 0 0 0 0 0 0 0 0 0 0 2.5889 -0.6018 -1.1749 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9392 -0.8269 -2.3367 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5555 -0.5178 -0.0804 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2803 -0.2025 1.1782 N 0 0 0 0 0 0 0 0 0 0 0 0 4.4766 -0.2407 1.8534 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5061 -0.5756 1.0043 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9028 -0.7424 -0.2060 N 0 0 0 0 0 0 0 0 0 0 0 0 5.5996 -1.1058 -1.4181 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6964 -0.1622 0.4278 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8064 -0.0611 0.2416 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.5080 -1.1541 1.0213 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8790 -1.9380 1.7343 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8754 -1.2476 0.9211 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.5800 -2.2758 1.6489 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0098 -2.2073 1.1467 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.1595 -0.8085 0.5745 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7601 -0.4058 0.1505 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2957 1.3026 0.6678 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 2 4 1 0 4 5 1 0 6 5 1 6 6 7 1 0 7 8 1 0 8 9 1 0 9 10 2 0 9 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 1 0 8 17 1 0 17 18 1 0 18 19 1 1 19 20 2 0 19 21 1 0 21 22 1 0 22 23 1 0 23 24 1 0 24 25 1 0 18 26 1 0 26 4 1 0 18 6 1 0 25 21 1 0 15 11 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |